Authors:
JOHNSON AA
OLESEN EH
ROSENGARD AM
LESLIE RGQ
Citation: Aa. Johnson et al., CHARACTERIZATION OF AP ACTIVATION BY NORMAL B-CELLS, RAJI CELLS AND CR-2-TRANSFECTED CELL-LINES, Molecular immunology, 35(6-7), 1998, pp. 173-173
Authors:
OLESEN EH
JOHNSON AA
DAMGAARD G
LESLIE RGQ
Citation: Eh. Olesen et al., THE REQUIREMENT OF LOCALIZED, CR-2-MEDIATED, ALTERNATIVE PATHWAY ACTIVATION OF COMPLEMENT FOR COVALENT DEPOSITION OF C3 FRAGMENTS ON NORMALB-CELLS, Immunology, 93(2), 1998, pp. 177-183
Authors:
NIELSEN CH
RASMUSSEN JM
VOSS A
JUNKER P
LESLIE RGQ
Citation: Ch. Nielsen et al., DIMINISHED ABILITY OF ERYTHROCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS TO LIMIT OPSONIZED IMMUNE-COMPLEX DEPOSITION ON LEUKOCYTES AND ACTIVATION OF GRANULOCYTES, Arthritis and rheumatism, 41(4), 1998, pp. 613-622
Authors:
MARQUART HV
OLESEN EH
JOHNSON AA
DAMGAARD G
LESLIE RGQ
Citation: Hv. Marquart et al., A COMPARATIVE-STUDY OF NORMAL B-CELLS AND THE EBV-POSITIVE BURKITTS-LYMPHOMA CELL-LINE, RAJI, AS ACTIVATORS OF THE COMPLEMENT-SYSTEM, Scandinavian journal of immunology, 46(3), 1997, pp. 246-253
Citation: Hv. Marquart et al., COMPLEMENT-ACTIVATING ABILITY OF LEUKOCYTES FROM PATIENTS WITH COMPLEMENT FACTOR-I DEFICIENCY, Immunology, 91(3), 1997, pp. 486-492
Authors:
NIELSEN CH
MATTHIESEN SH
LYNG I
LESLIE RGQ
Citation: Ch. Nielsen et al., THE ROLE OF COMPLEMENT RECEPTOR-TYPE-1 (CR-1, CD35) IN DETERMINING THE CELLULAR-DISTRIBUTION OF OPSONIZED IMMUNE-COMPLEXES BETWEEN WHOLE-BLOOD CELLS - KINETIC-ANALYSIS OF THE BUFFERING CAPACITY OF ERYTHROCYTES, Immunology, 90(1), 1997, pp. 129-137
Authors:
NIELSEN CH
ANTONSEN S
MATTHIESEN SH
LESLIE RGQ
Citation: Ch. Nielsen et al., THE ROLES OF COMPLEMENT RECEPTORS TYPE-1 (CR-1, CD35) AND TYPE-3 (CR3, CD11B CD18) IN THE REGULATION OF THE IMMUNE COMPLEX-ELICITED RESPIRATORY BURST OF POLYMORPHONUCLEAR LEUKOCYTES IN WHOLE-BLOOD/, European Journal of Immunology, 27(11), 1997, pp. 2914-2919
Authors:
MARQUART HV
GRONBAEK K
CHRISTENSEN BE
SVEHAG SE
LESLIE RGQ
Citation: Hv. Marquart et al., COMPLEMENT ACTIVATION BY MALIGNANT B-CELLS FROM PATIENTS WITH CHRONICLYMPHOCYTIC-LEUKEMIA (CLL), Clinical and experimental immunology, 102(3), 1995, pp. 575-581
Authors:
MARQUART HV
SVENDSEN A
RASMUSSEN JM
NIELSEN CH
JUNKER P
SVEHAG SE
LESLIE RGQ
Citation: Hv. Marquart et al., COMPLEMENT RECEPTOR EXPRESSION AND ACTIVATION OF THE COMPLEMENT CASCADE ON B-LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Clinical and experimental immunology, 101(1), 1995, pp. 60-65
Authors:
NIELSEN CH
SVEHAG SE
MARQUART HV
LESLIE RGQ
Citation: Ch. Nielsen et al., INTERACTIONS OF OPSONIZED IMMUNE-COMPLEXES WITH WHOLE-BLOOD CELLS - BINDING TO ERYTHROCYTES RESTRICTS COMPLEX UPTAKE BY LEUKOCYTE POPULATIONS, Scandinavian journal of immunology, 40(2), 1994, pp. 228-236
Citation: Hv. Marquart et al., CR-2 IS THE PRIMARY ACCEPTOR SITE FOR C3 DURING ALTERNATIVE PATHWAY ACTIVATION OF COMPLEMENT ON HUMAN PERIPHERAL B-LYMPHOCYTES, The Journal of immunology, 153(1), 1994, pp. 307-315